Ademetionine

DB00118ApprovedInvestigationalNutraceuticalSmall molecule

Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From... (From Merck, 11th ed).

Chemical structure of Ademetionine
Mechanism
Curator reviewed
Primary indication
S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis.Curator reviewed · 7 structured indications
Formula / weight
C15H22N6O5S · 398.44 g/mol (avg)
Also known as
AdoMet · L-S-Adenosylmethionine · S-Adenosylmethionine · SAM-e · SAMe

Resolves to

Structure
InChIKeyMEFKEPWMEQBLKI-AIRLBKTGSA-NSMILESC[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N

What you can answer from here — as of September 12, 2026

8Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
29Drug interactionsStructured to mechanism, not free text
Sign in
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
23Marketed productsAcross 3 countries and 6 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
37+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ademetionine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account